london euretina

This meeting has been awarded 20 CME credits

Security Notice

Please note that Kuoni are our only destination management company. Other venders indicating that are operating for the society should be ignored. We never use western union as a payment portal

Posters

Analysis of choroidal thickness in eyes with diabetic macular edema treated with resveratrol and ranibizumab using SD-OCT

Poster Details

First Author: G.Martone ITALY

Co Author(s):    C. Traversi   E. Nuti   P. Pichierri   A. Tarantello         0   0 0   0 0   0 0   0 0

Abstract Details



Purpose:

To analyse the effect of resveratrol and ranibizumab therapy on subfoveal choroidal thickness (SFCT) in patients with diabetic macular edema (DME) using spectral-domain optical coherence tomography (SD-OCT).

Setting:

Ophthalmology Department, University of Siena, Italy

Methods:

This prospective study evaluated the mean SFCT before and at 6 months after resveratrol treatment in 12 eyes treated also with ranibizumab injections for diabetic macular edema. Enhanced depth imaging optical coherence tomography (EDI-OCT) was performed to measure SFCT .

Results:

Mean SFCT was 338.5 μm and 277.4 μm before and at 6 months after treatment, respectively. OCT measurements showed a significant decrease in the mean SFCT after treatment at 6 months follow-up (p=.03). The mean number of injections was 4.1±0.8.

Conclusions:

Diabetic eyes with macular edema treated with resveratrol and ranibizumab showed a decrease of SFCT. The choroidal thickness decreased after treatment, suggesting after this treatment could be an improvement of anti-angiogenic and anti-inflammatory effect suggesting for a reduced choroidal vascular permeability.

Back to previous
EURETINA, Temple House, Temple Road, Blackrock, Co Dublin. | Phone: 00353 1 2100092 | Fax: 00353 1 2091112 | Email: euretina@euretina.org

Privacy policyHotel Terms and Conditions Cancellation policy